Q3 FY26 results: PAT Rs 41 cr on Rs 372 cr revenue; director changes
INDRAMEDCO · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 0.6 pts more than Nifty Microcap 250 and 1.6 pts more than its Hospital peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Indraprastha Apollo Hospitals posted Q3 FY26 revenue from operations of Rs 371.61 cr (up 14.4% YoY from Rs 324.93 cr) and PAT of Rs 41 cr (up nearly 25% from Rs 32.81 cr). Nine-month revenue was Rs 1,117.7 cr with PAT of Rs 141.9 cr. Board noted fresh affidavit by Delhi govt in the pending Supreme Court land lease case. New Labour Codes added Rs 2.87 cr liability. One new Independent Director appointed; three re-appointed for 5-year terms.
Strong quarter with PAT up nearly 25%. The Delhi land lease matter in Supreme Court remains a key risk for shareholders.